IGES MedTech
IGES MedTech is a multinational team of experts for all aspects of market access and reimbursement of medical devices in Europe. Our comprehensive, pan-European approach helps to open up European markets strategically and quickly. IGES MedTech has its European headquarters in Berlin. It combines the expertise and excellent scientific work of these four companies:
AiM supports the medical device industry in accessing the German-speaking markets in Europe. AiM is a specialist for all questions regarding market access, reimbursement and pricing in Germany, Austria and Switzerland. The focus is on identifying the right reimbursement pathways in the outpatient and inpatient sector.
Since its foundation in 2007, AiM has successfully completed more than 800 projects for more than 250 clients.
AiM is based in Lörrach, Germany.
Device Access UK goals are to help get great technologies to patients faster. Since 2010, it has helped 100’s of MedTech clients gain product adoption faster within NHS Hospitals, as well as help them gain recommendations and approvals though the National Institute for Health & Care Excellence (NICE)
Established in 2010, Device Access has supported over 45 successful applications through NICE approval, as well as supporting its Medtech clients accelerate adoption within hospitals through the provision of specific device dossiers and budget impact models.
Device Access is based in Southampton, UK.
Highly specialized, and with a lot of enthusiasm, Meditech Access helps medical device innovators to enter the French-speaking markets. Meditech Access' particular strength is the development of sustainable concepts that give companies security and ensure that patients are quickly provided with valuable medical technology innovations.
Meditech Access was founded in 2012. A large number of projects have been successfully implemented since then. Today, Meditech Access is recognized as a powerful provider of market access solutions for France.
Meditech Access is based in Versailles, France.
Synergus RWE supports Medical Device, Diagnostics and Digital Solutions to develop and execute market access strategies across western Europe. This includes services from early advice on required evidence, strategies for market access all the way to supporting dossier submissions.
Even though the company is based in Sweden, most of the work is for other countries. Leveraging the unique Real Wold Data sources in Sweden, Synergus RWE also provides Real-World-Evidence studies.
Synergus RWE is based in Åkersberga, Sweden.
Since 2020, the four IGES companies AiM, Device Access, Meditech Access and Synergus form IGES MedTech.
Together, they support medical technology innovators from all over the world to access the European markets, thoroughly, rapidly and sustainably. High expertise, enthusiasm and scientific diligence are the basis of our support.
Prof Dr Bertram Häussler, Chairman of the IGES Institut
Accessing Europe - We pave the way for innovative medical devices
From clinical trial planning to product lifecycle management, we help you successfully access the European markets and find the solution tailored to your individual needs.
Leadership
Prof Dr
Bertram Häussler
Chairman
IGES Institut – Germany
Michael
Weisser
CEO
AiM - Germany
Michael
Branagan-Harris
CEO
Device Access – UK
Michel
Verhasselt
Founder
and CEO
Meditech Access - France
Claire
Moreau
General Manager – Market Access
Meditech Access – France
Mattias
Kyhlstedt
CEO
Synergus - Sweden
Marc
Kurepkat
CEO
CSG - Germany
